Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Clinical Services Laboratory, |
RCV000778209 | SCV000914375 | uncertain significance | CRB1-Related Disorders | 2018-12-10 | criteria provided, single submitter | clinical testing | The CRB1 c.1183G>T (p.Glu395Ter) variant is a stop-gained variant predicted to result in premature termination of the protein. The p.Glu395Ter variant has been reported in one study in which it is found in one individual with Leber congenital amaurosis who also carried a frameshift variant in the CRB1 gene (Carss et al. 2017). Control data are unavailable for the p.Glu395Ter variant which is reported at a frequency of 0.000229 in the African population from the Genome Aggregation Database, however this is based on two alleles in a region of good seqeunce coverage so the variant is presumed to be rare. Based on the evidence and the potential impact of stop-gained variants, the p.Glu395Ter variant is classified as a variant of unknown significance, but suspicious for pathogenicity for CRB1-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. |
Blueprint Genetics | RCV001074835 | SCV001240435 | likely pathogenic | Retinal dystrophy | 2019-07-23 | criteria provided, single submitter | clinical testing | |
NIHR Bioresource Rare Diseases, |
RCV000505025 | SCV000598908 | likely pathogenic | Leber congenital amaurosis | 2015-01-01 | no assertion criteria provided | research |